Catalysts for Intra-Cellular Therapies Inc
7 tracked
Nov 5, 2025
approval
CAPLYTA (LUMATEPERONE TOSYLATE) — FDA approval
lumateperone tosylate
→
Jun 28, 2023
approval
CAPLYTA (LUMATEPERONE TOSYLATE) — FDA approval
lumateperone tosylate
→
Apr 26, 2022
approval
CAPLYTA (LUMATEPERONE TOSYLATE) — FDA approval
lumateperone tosylate
→
Dec 17, 2021
approval
CAPLYTA (LUMATEPERONE TOSYLATE) — FDA approval
lumateperone tosylate
→
Dec 17, 2021
approval
CAPLYTA (LUMATEPERONE TOSYLATE) — FDA approval
lumateperone tosylate
→
Dec 20, 2019
approval
CAPLYTA (LUMATEPERONE TOSYLATE) — FDA approval
lumateperone tosylate
→
Dec 20, 2019
approval
CAPLYTA (LUMATEPERONE TOSYLATE) — FDA approval
lumateperone tosylate
→